← Back

Enhancing Mechanistic Research on Precision Probiotic Therapies (R61/R33 Clinical Trial Optional)

This grant supports highly innovative mechanistic research to accelerate precision probiotic interventions by identifying host biological patterns that influence probiotic responses. It funds an initial phase to characterize these patterns using observational or secondary data, followed by a second phase to test their ability to improve probiotic responsiveness in mechanistic studies with animal models or humans.

Amount
Not stated
Type
Grant

Key facts

Key facts for Enhancing Mechanistic Research on Precision Probiotic Therapies (R61/R33 Clinical Trial Optional)
AmountNot stated
IssuerNational Institutes of Health
Who can applySmall businesses, companies, universities and 7 more
SectorsEdTech · HealthTech
DeadlineCloses 02 Jun 2027

Unlock application details

See all eligibility criteria, required documents and the official application link. Free account, no card.

Update history

Source: grants.gov ↗

Source checked 2 days ago

  1. 85 days agoagentImported from the official source